WAYNE, Pa., July 17, 2015 /PRNewswire/ -- Ryan &
Maniskas, LLP is investigating potential claims against the board
of directors of Receptos, Inc. ("Receptos" or the "Company")
(NASDAQ: RCPT) concerning possible breaches of fiduciary duty and
other violations of law related to the Company's efforts to sell
the Company to Celgene Corporation in a transaction valued at
approximately $7.2 billion.
If you own shares of Receptos and would like to learn more about
this class action or if you wish to discuss these matters and have
any questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire
toll-free at (877) 316-3218 or to sign up online, visit:
www.rmclasslaw.com/cases/rcpt. You may also email Mr.
Maniskas at rmaniskas@rmclasslaw.com.
Under the terms of the agreement, shareholders of Receptos will
receive $232.00 in cash for each
share of Receptos they own.
Our investigation concerns possible breaches of fiduciary duty
and other violations of state law by the Board of Directors of
Receptos for not acting in the Company's shareholders' best
interests in connection with the sale process.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide. To learn more
about the class action process, please visit:
www.rmclasslaw.com.
CONTACT: Ryan & Maniskas, LLP
Richard A. Maniskas, Esquire
995 Old
Eagle School Rd., Suite 311
Wayne, PA
19087
877-316-3218
www.rmclasslaw.com/cases/rcpt
rmaniskas@rmclasslaw.com
Logo -
http://photos.prnewswire.com/prnh/20121112/MM11729LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ryan--maniskas-llp-investigation-of-receptos-inc-300114966.html
SOURCE Ryan & Maniskas, LLP